A study suggested that a new type of cell therapy may improve the prognosis of patients critically unwell with acute respiratory distress syndrome caused by severe COVID-19. New type of cell therapy shows promise for ARDS patients: Study Professor Justin Stebbing of Anglia Ruskin University is a joint senior author of a new study published in the journal Nature Communications …
